
Results
37
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
37 companies
Horizon Robotics
Market Cap: HK$102.8b
An investment holding company, provides automotive solutions for passenger vehicles in China.
9660
HK$7.02
7D
-3.2%
1Y
1.7%
TK Group (Holdings)
Market Cap: HK$2.0b
An investment holding company, engages in the manufacture, sale, subcontracting, fabrication, and modification of molds and plastic components.
2283
HK$2.36
7D
0%
1Y
9.3%
Precision Tsugami (China)
Market Cap: HK$20.2b
An investment holding company, manufactures and sells computer numerical control machine tools primarily in Mainland China.
1651
HK$54.90
7D
15.1%
1Y
153.6%
Shoucheng Holdings
Market Cap: HK$14.1b
An investment holding company, engages in the infrastructure asset management business.
697
HK$1.72
7D
6.2%
1Y
8.2%
Beijing Luzhu Biotechnology
Market Cap: HK$4.4b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$22.08
7D
-4.8%
1Y
3.2%
Peijia Medical
Market Cap: HK$3.9b
Engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China.
9996
HK$5.84
7D
-5.7%
1Y
4.8%
Shenzhen Edge Medical
Market Cap: HK$20.8b
Engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China.
2675
HK$53.05
7D
0.7%
1Y
n/a
XD
Market Cap: HK$31.0b
An investment holding company, develops, publishes, operates, and distributes mobile and web games in Mainland China and internationally.
2400
HK$64.80
7D
3.8%
1Y
78.0%
Keymed Biosciences
Market Cap: HK$21.2b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$71.95
7D
-4.8%
1Y
71.1%
GenFleet Therapeutics (Shanghai)
Market Cap: HK$15.5b
Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.
2595
HK$41.80
7D
-3.1%
1Y
n/a
Guming Holdings
Market Cap: HK$59.6b
An investment holding company, operates as a freshly made beverage company in the People’s Republic of China.
1364
HK$25.08
7D
-1.6%
1Y
1.1%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$42.7b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$51.45
7D
-1.8%
1Y
323.8%
Damai Entertainment Holdings
Market Cap: HK$18.3b
An investment holding company, operates in the content, technology, and IP merchandising and commercialization businesses in Hong Kong and the People's Republic of China.
1060
HK$0.61
7D
5.2%
1Y
24.5%
Innovent Biologics
Market Cap: HK$156.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$90.00
7D
0%
1Y
71.8%
CanSino Biologics
Market Cap: HK$12.3b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$30.80
7D
4.8%
1Y
-2.7%
Ocumension Therapeutics
Market Cap: HK$5.7b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$7.00
7D
-5.4%
1Y
32.3%
Laopu Gold
Market Cap: HK$104.7b
Designs, manufactures, and sells jewelry products in Mainland China, Hong Kong, and Macau.
6181
HK$592.50
7D
7.3%
1Y
-15.2%
WuXi XDC Cayman
Market Cap: HK$70.6b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$56.00
7D
-4.9%
1Y
50.9%
Zylox-Tonbridge Medical Technology
Market Cap: HK$7.5b
A medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.
2190
HK$22.48
7D
-2.0%
1Y
16.6%
Ubtech Robotics
Market Cap: HK$57.0b
Engages in the research, design, development, production, commercialization, marketing, and sale of robotic products and services in China, Hong Kong, and internationally.
9880
HK$113.40
7D
7.0%
1Y
42.6%
Shiyue Daotian Group
Market Cap: HK$6.6b
Manufactures and sells pantry staple food in the People's Republic of China.
9676
HK$6.21
7D
-2.1%
1Y
-5.0%
Akeso
Market Cap: HK$123.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$134.00
7D
-1.3%
1Y
58.9%
Mao Geping Cosmetics
Market Cap: HK$35.4b
Provides color cosmetics and skincare products under the MAOGEPING and Love Keeps brands in China.
1318
HK$72.30
7D
0.3%
1Y
-30.3%
Super Hi International Holding
Market Cap: HK$6.9b
An investment holding company, engages in the restaurant operation, delivery business, and others in Asia, North America, Europe, Oceania, and internationally.
9658
HK$10.60
7D
-1.2%
1Y
-40.4%
China State Construction Development Holdings
Market Cap: HK$1.9b
An investment holding company, engages in the general contracting business in Hong Kong and internationally.
830
HK$0.86
7D
-2.3%
1Y
-48.2%
Zijin Gold International
Market Cap: HK$461.7b
An investment holding company, engages in the exploration, mining, processing, smelting, refining, and sale of gold and other non-ferrous metals.
2259
HK$172.50
7D
14.4%
1Y
n/a
Shanghai MicroPort MedBot (Group)
Market Cap: HK$29.9b
Shanghai MicroPort MedBot (Group) Co., Ltd.
2252
HK$29.02
7D
-6.4%
1Y
53.9%
Zibuyu Group
Market Cap: HK$2.2b
An investment holding company, operates as a cross-border e-commerce company in China in North America, Asia, Europe, and internationally.
2420
HK$4.39
7D
-1.1%
1Y
12.0%
MicroTech Medical (Hangzhou)
Market Cap: HK$3.2b
Provides diabetes management, diabetes treatment, and diabetes monitoring medical devices in China and internationally.
2235
HK$7.80
7D
-2.4%
1Y
22.6%
Cutia Therapeutics
Market Cap: HK$1.7b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$4.58
7D
-0.4%
1Y
-26.1%
Bairong
Market Cap: HK$3.1b
An investment holding company, operates as an artificial intelligence (AI) technology services company in China.
6608
HK$6.95
7D
-1.0%
1Y
-15.0%
Busy Ming Group
Market Cap: HK$98.0b
Through its subsidiaries, operates as a food and beverage retailer in China.
1768
HK$449.80
7D
3.4%
1Y
n/a
Bank of East Asia
Market Cap: HK$37.0b
Provides various banking and related financial services.
23
HK$14.01
7D
2.4%
1Y
26.0%
Tongguan Gold Group
Market Cap: HK$16.5b
An investment holding company, engages in the exploration, mining, processing, smelting, and sale of gold and related products in China.
340
HK$3.10
7D
8.8%
1Y
156.2%
Auntea Jenny (Shanghai) Industrial
Market Cap: HK$15.5b
Auntea Jenny (Shanghai) Industrial Co., Ltd.
2589
HK$147.60
7D
-6.0%
1Y
2.1%
Xunfei Healthcare Technology
Market Cap: HK$9.6b
Provides healthcare AI solutions in the People’s Republic of China.
2506
HK$79.40
7D
9.7%
1Y
-26.2%